Αρχειοθήκη ιστολογίου

Δευτέρα 11 Σεπτεμβρίου 2017

Vemurafenib for high risk melanoma patients

Dr Lewis presents in a press conference at the ESMO 2017 Congress in Madrid data from a randomised, double-blind, placebo-controlled study of adjuvant vemurafenib in patients with completely resected, BRAFV600 melanoma at high risk for recurrence. Dr...

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2eZd76e
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader